Matthew Doepker, MD
Surgical Oncology · Centerville, OHNPI 1316232606
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,981 of the $4,885 with a category attached, or 61.0%. 14 manufacturers reported payments, led by Medtronic at 47.5% of the total. 2025 is the largest year on record at $3,165, 2.4 times the $1,328 reported in 2019.
Across 64 payments — averaging $76.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Covidien LP$1K
- Intuitive Surgical$508
- Dilon Technologies, Inc.$204
- Regeneron Healthcare Solutions, Inc.$193
- AbbVie$133
- plus $372 from 8 others
What the payments were for
- Travel & lodging$2,98161%
- Food & beverage$1,88839%
- Education$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 23 | $2,318 |
| Covidien LP | 7 | $1,157 |
| Intuitive Surgical | 7 | $508 |
| Dilon Technologies, Inc. | 4 | $204 |
| Regeneron Healthcare Solutions, Inc. | 5 | $193 |
| AbbVie | 5 | $133 |
| Angiodynamics, Inc. | 1 | $122 |
| Merck | 5 | $97 |
| KCI USA, Inc. | 1 | $48 |
| Solventum Corporation | 2 | $33 |
| Boehringer Ingelheim | 1 | $25 |
| Genentech USA, Inc. | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Signia$1,809
- Sonicision$1,011
- Da Vinci Surgical System$378
- HemoBlast Bellows$135
- LIBTAYO$123
How this compares
$4,885 in reported general payments places this provider in the 85th percentile of 69 surgical oncology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 14 | $84 |
| Metronidazole | 14 | $25 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Centerville
- James OuelletteCenterville$20K
- Selyne SamuelCenterville$4K
- Syed AhmadCincinnati$59K
- Rebecca TuttleKettering$28K
- Carl SchmidtColumbus$26K
- Mary DillhoffColumbus$15K
- Alicia HeelanCincinnati$9K
- Susan TsaiColumbus$8K
- Joal BeaneColumbus$8K
- John AmmoriCleveland$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.